ワクチン受託製造の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Vaccine Contract Manufacturing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16852 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥528,960 (USD3,480)	▷ お問い合わせ
Multi User	￥793,440 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,057,920 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ワクチン受託製造の世界市場を広く調査・分析し、今後の市場展望をまとめております。ワクチン受託製造の種類別市場規模（塗りつぶし、バルク品）、用途別市場規模（製薬企業、バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Diosynth、Bavarian Nordic、Emergent BioSolutions、Goodwin Biotechnology、Catalent Biologics、Soligenix Inc ・地域別グローバル市場分析 2015年-2020年 ・ワクチン受託製造の北米市場（アメリカ、カナダ、メキシコ） ・ワクチン受託製造のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ワクチン受託製造のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ワクチン受託製造の南米市場（ブラジル、アルゼンチン） ・ワクチン受託製造の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：塗りつぶし、バルク品 ・用途別分析：製薬企業、バイオテクノロジー企業、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Vaccine Contract Manufacturing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2115.8 million by 2025, from USD 1737.6 million in 2019.

The Vaccine Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Vaccine Contract Manufacturing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Vaccine Contract Manufacturing market has been segmented into:
Fill-Finish
Bulk Product

By Application, Vaccine Contract Manufacturing has been segmented into:
Pharmaceutical Companies
Biotech Companies
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine Contract Manufacturing market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine Contract Manufacturing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine Contract Manufacturing market.

The report offers in-depth assessment of the growth and other aspects of the Vaccine Contract Manufacturing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Vaccine Contract Manufacturing Market Share Analysis
Vaccine Contract Manufacturing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine Contract Manufacturing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine Contract Manufacturing sales, revenue and market share for each player covered in this report.

The major players covered in Vaccine Contract Manufacturing are:
Diosynth
Bavarian Nordic
Emergent BioSolutions
Goodwin Biotechnology
Catalent Biologics
Soligenix Inc

レポート目次

---

Table of Contents

1 Vaccine Contract Manufacturing Market Overview
1.1 Product Overview and Scope of Vaccine Contract Manufacturing
1.2 Classification of Vaccine Contract Manufacturing by Type
1.2.1 Global Vaccine Contract Manufacturing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Vaccine Contract Manufacturing Revenue Market Share by Type in 2019
1.2.3 Fill-Finish
1.2.4 Bulk Product
1.3 Global Vaccine Contract Manufacturing Market by Application
1.3.1 Overview: Global Vaccine Contract Manufacturing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Global Vaccine Contract Manufacturing Market by Regions
1.4.1 Global Vaccine Contract Manufacturing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Vaccine Contract Manufacturing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Vaccine Contract Manufacturing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Vaccine Contract Manufacturing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Vaccine Contract Manufacturing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Vaccine Contract Manufacturing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Vaccine Contract Manufacturing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Diosynth
2.1.1 Diosynth Details
2.1.2 Diosynth Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Diosynth SWOT Analysis
2.1.4 Diosynth Product and Services
2.1.5 Diosynth Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bavarian Nordic SWOT Analysis
2.2.4 Bavarian Nordic Product and Services
2.2.5 Bavarian Nordic Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Emergent BioSolutions
2.3.1 Emergent BioSolutions Details
2.3.2 Emergent BioSolutions Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Emergent BioSolutions SWOT Analysis
2.3.4 Emergent BioSolutions Product and Services
2.3.5 Emergent BioSolutions Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Goodwin Biotechnology
2.4.1 Goodwin Biotechnology Details
2.4.2 Goodwin Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Goodwin Biotechnology SWOT Analysis
2.4.4 Goodwin Biotechnology Product and Services
2.4.5 Goodwin Biotechnology Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Catalent Biologics
2.5.1 Catalent Biologics Details
2.5.2 Catalent Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Catalent Biologics SWOT Analysis
2.5.4 Catalent Biologics Product and Services
2.5.5 Catalent Biologics Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Soligenix Inc
2.6.1 Soligenix Inc Details
2.6.2 Soligenix Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Soligenix Inc SWOT Analysis
2.6.4 Soligenix Inc Product and Services
2.6.5 Soligenix Inc Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Vaccine Contract Manufacturing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Vaccine Contract Manufacturing Players Market Share
3.2.2 Top 10 Vaccine Contract Manufacturing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Vaccine Contract Manufacturing Revenue and Market Share by Regions
4.2 North America Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.3 Europe Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.5 South America Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
5 North America Vaccine Contract Manufacturing Revenue by Countries
5.1 North America Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
5.2 USA Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
5.3 Canada Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
5.4 Mexico Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
6 Europe Vaccine Contract Manufacturing Revenue by Countries
6.1 Europe Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
6.2 Germany Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.3 UK Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.4 France Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.5 Russia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
6.6 Italy Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Vaccine Contract Manufacturing Revenue by Countries
7.1 Asia-Pacific Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
7.2 China Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.3 Japan Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.4 Korea Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.5 India Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
8 South America Vaccine Contract Manufacturing Revenue by Countries
8.1 South America Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
8.2 Brazil Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
8.3 Argentina Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Vaccine Contract Manufacturing by Countries
9.1 Middle East & Africa Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.3 UAE Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.4 Egypt Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
9.5 South Africa Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Vaccine Contract Manufacturing Revenue and Market Share by Type (2015-2020)
10.2 Global Vaccine Contract Manufacturing Market Forecast by Type (2019-2024)
10.3 Fill-Finish Revenue Growth Rate (2015-2025)
10.4 Bulk Product Revenue Growth Rate (2015-2025)
11 Global Vaccine Contract Manufacturing Market Segment by Application
11.1 Global Vaccine Contract Manufacturing Revenue Market Share by Application (2015-2020)
11.2 Vaccine Contract Manufacturing Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Companies Revenue Growth (2015-2020)
11.4 Biotech Companies Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Vaccine Contract Manufacturing Market Size Forecast (2021-2025)
12.1 Global Vaccine Contract Manufacturing Market Size Forecast (2021-2025)
12.2 Global Vaccine Contract Manufacturing Market Forecast by Regions (2021-2025)
12.3 North America Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
12.4 Europe Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
12.6 South America Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Vaccine Contract Manufacturing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine Contract Manufacturing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Vaccine Contract Manufacturing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Diosynth Corporate Information, Location and Competitors
Table 6. Diosynth Vaccine Contract Manufacturing Major Business
Table 7. Diosynth Vaccine Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 8. Diosynth SWOT Analysis
Table 9. Diosynth Vaccine Contract Manufacturing Product and Solutions
Table 10. Diosynth Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bavarian Nordic Corporate Information, Location and Competitors
Table 12. Bavarian Nordic Vaccine Contract Manufacturing Major Business
Table 13. Bavarian Nordic Vaccine Contract Manufacturing Total Revenue (USD Million) (2018-2019)
Table 14. Bavarian Nordic SWOT Analysis
Table 15. Bavarian Nordic Vaccine Contract Manufacturing Product and Solutions
Table 16. Bavarian Nordic Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Emergent BioSolutions Corporate Information, Location and Competitors
Table 18. Emergent BioSolutions Vaccine Contract Manufacturing Major Business
Table 19. Emergent BioSolutions Vaccine Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 20. Emergent BioSolutions SWOT Analysis
Table 21. Emergent BioSolutions Vaccine Contract Manufacturing Product and Solutions
Table 22. Emergent BioSolutions Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Goodwin Biotechnology Corporate Information, Location and Competitors
Table 24. Goodwin Biotechnology Vaccine Contract Manufacturing Major Business
Table 25. Goodwin Biotechnology Vaccine Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 26. Goodwin Biotechnology SWOT Analysis
Table 27. Goodwin Biotechnology Vaccine Contract Manufacturing Product and Solutions
Table 28. Goodwin Biotechnology Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Catalent Biologics Corporate Information, Location and Competitors
Table 30. Catalent Biologics Vaccine Contract Manufacturing Major Business
Table 31. Catalent Biologics Vaccine Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 32. Catalent Biologics SWOT Analysis
Table 33. Catalent Biologics Vaccine Contract Manufacturing Product and Solutions
Table 34. Catalent Biologics Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Soligenix Inc Corporate Information, Location and Competitors
Table 36. Soligenix Inc Vaccine Contract Manufacturing Major Business
Table 37. Soligenix Inc Vaccine Contract Manufacturing Total Revenue (USD Million) (2017-2018)
Table 38. Soligenix Inc SWOT Analysis
Table 39. Soligenix Inc Vaccine Contract Manufacturing Product and Solutions
Table 40. Soligenix Inc Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Vaccine Contract Manufacturing Revenue (Million USD) by Players (2015-2020)
Table 42. Global Vaccine Contract Manufacturing Revenue Share by Players (2015-2020)
Table 43. Global Vaccine Contract Manufacturing Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Vaccine Contract Manufacturing Revenue Market Share by Regions (2015-2020)
Table 45. North America Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
Table 46. North America Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 47. Europe Vaccine Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Vaccine Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Vaccine Contract Manufacturing Revenue by Countries (2015-2020)
Table 50. South America Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Vaccine Contract Manufacturing Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Table 53. Global Vaccine Contract Manufacturing Revenue (Million USD) by Type (2015-2020)
Table 54. Global Vaccine Contract Manufacturing Revenue Share by Type (2015-2020)
Table 55. Global Vaccine Contract Manufacturing Revenue Forecast by Type (2021-2025)
Table 56. Global Vaccine Contract Manufacturing Revenue by Application (2015-2020)
Table 57. Global Vaccine Contract Manufacturing Revenue Share by Application (2015-2020)
Table 58. Global Vaccine Contract Manufacturing Revenue Forecast by Application (2021-2025)
Table 59. Global Vaccine Contract Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Vaccine Contract Manufacturing Picture
Figure 2. Global Vaccine Contract Manufacturing Revenue Market Share by Type in 2019
Figure 3. Fill-Finish Picture
Figure 4. Bulk Product Picture
Figure 5. Vaccine Contract Manufacturing Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Companies Picture
Figure 7. Biotech Companies Picture
Figure 8. Others Picture
Figure 9. Global Vaccine Contract Manufacturing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Vaccine Contract Manufacturing Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Vaccine Contract Manufacturing Revenue Market Share in 2019
Figure 18. Global Top 10 Players Vaccine Contract Manufacturing Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Vaccine Contract Manufacturing Revenue Market Share by Regions (2015-2020)
Figure 22. Global Vaccine Contract Manufacturing Revenue Market Share by Regions in 2018
Figure 23. North America Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 24. Europe Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 26. South America Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 28. North America Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 29. North America Vaccine Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 30. USA Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 31. Canada Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Vaccine Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 35. Germany Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 36. UK Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 37. France Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 38. Russia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 39. Italy Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Vaccine Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 42. China Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 43. Japan Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 44. Korea Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 45. India Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 47. South America Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 48. South America Vaccine Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 49. Brazil Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Vaccine Contract Manufacturing Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Vaccine Contract Manufacturing Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 54. UAE Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Vaccine Contract Manufacturing Revenue and Growth Rate (2015-2020)
Figure 57. Global Vaccine Contract Manufacturing Revenue Share by Type (2015-2020)
Figure 58. Global Vaccine Contract Manufacturing Revenue Share by Type in 2019
Figure 59. Global Vaccine Contract Manufacturing Market Share Forecast by Type (2021-2025)
Figure 60. Global Fill-Finish Revenue Growth Rate (2015-2020)
Figure 61. Global Bulk Product Revenue Growth Rate (2015-2020)
Figure 62. Global Vaccine Contract Manufacturing Revenue Share by Application (2015-2020)
Figure 63. Global Vaccine Contract Manufacturing Revenue Share by Application in 2019
Figure 64. Global Vaccine Contract Manufacturing Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 66. Global Biotech Companies Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Vaccine Contract Manufacturing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Vaccine Contract Manufacturing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Vaccine Contract Manufacturing Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 72. Europe Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 74. South America Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Vaccine Contract Manufacturing Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---